These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32077762)

  • 1. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.
    Göçer K; Aykan AÇ; Kılınç M; Göçer NS
    Scand J Clin Lab Invest; 2020 Jul; 80(4):277-281. PubMed ID: 32077762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy.
    Kadoglou NP; Kottas G; Lampropoulos S; Vitta I; Liapis CD
    Clin Drug Investig; 2014 Mar; 34(3):165-71. PubMed ID: 24307429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.
    Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Ko YL
    Biomark Med; 2019 Jun; 13(9):751-760. PubMed ID: 31157557
    [No Abstract]   [Full Text] [Related]  

  • 6. Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults.
    Akin F; Celik O; Ayca B; Altun I; Diker VO; Bıyık I; Siriopol D; Covic A; Kanbay M
    J Investig Med; 2015 Apr; 63(4):613-9. PubMed ID: 25679296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease.
    Adamczyk T; Mizia-Stec K; Mizia M; Haberka M; Chmiel A; Chudek J; Gąsior Z
    Pol Arch Med Wewn; 2012; 122(1-2):14-21. PubMed ID: 22237719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between fetuin-A levels and fibroblast growth factor 23 with the severity of coronary artery disease measured by SYNTAX scores.
    Chen YC; Lin FY; Lin RH; Chuang CL; Chang CC; Tsai CS
    Am J Cardiol; 2013 Oct; 112(7):950-3. PubMed ID: 23795812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses.
    Luna-Luna M; Cruz-Robles D; Ávila-Vanzzini N; Herrera-Alarcón V; Martínez-Reding J; Criales-Vera S; Sandoval-Zárate J; Vargas-Barrón J; Martínez-Sánchez C; Tovar-Palacio AR; Fragoso JM; Carreón-Torres E; Vargas-Alarcón G; Pérez-Méndez Ó
    Lipids Health Dis; 2017 Aug; 16(1):156. PubMed ID: 28821297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum Klotho, fetuin-A, and MGP levels with coronary artery calcification in maintenance hemodialysis patients.
    Wang D; Chu X; Cao J; Peng Y
    Clinics (Sao Paulo); 2024; 79():100417. PubMed ID: 39089098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
    Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
    Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients].
    Janda K; Krzanowski M; Dumnicka P; Kuśnierz-Cabala B; Sułowicz W
    Przegl Lek; 2012; 69(12):1241-5. PubMed ID: 23750431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
    Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
    Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.
    Yan X; Sano M; Lu L; Wang W; Zhang Q; Zhang R; Wang L; Chen Q; Fukuda K; Shen W
    Cardiovasc Diabetol; 2010 Oct; 9():70. PubMed ID: 21034455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.
    Koluman BU; Mutluay R; Derici UB; Arinsoy T; Senlik Z; Bahar B; Sancak B; Oktan SO; Sindel S
    Clin Nephrol; 2013 Jul; 80(1):9-16. PubMed ID: 23458176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.